Ion Results
Ion Results will utilize Point-of-Care tests to automate results from a CLIA labratory while never having to send specimens off-site.
Ion Test Manager
Use any of point-of-care device at your pharmacy.
Manage patient appointments, provide results for POC testing.
Have the ability to provide CLIA certified test results from your pharmacy.
Use any of point-of-care device at your pharmacy.
-
Increase revenue and service offerings through Point-of-Care testing
-
Instant result documentation generated by CLIA certified laboratory
-
Scheduling software integrated into existing website
-
Streamline administrative duties - save time and labor without increasing expenses
Current List of Tests
Categorized within Ion Results
MITROPONIN
Point-of-care cardiac tests for the simultaneous qualitative detection of Troponin 1 in blood, plasma and serum for the rapid diagnosis of myocardial infarction.
hCG STRIP
Intended Use hCG One-Step Pregnancy Test is a simple immunoassay for the Qualitative Detection of Human Chorionic Gonadotropin (hCG) in Urine for the Early Detection of Pregnancy.
FLU A&B
Intended Use Flu A&B is an in vitro rapid qualitative test that detects influenza type A and type B nucleoprotein antigens directly from nasal swab, nasopharyngeal swab, and nasopharyngeal aspirate/was specimens obtained from patients.
STREP A STRIP
Intended Use Step A- Direct Grop A Streptococcus Antigen Test Strip is a rapid immunochromatographic assay for the qualitative detection of group A streptococcal antigen directly from throat swab specimens.
MONO
Intend Use Mono Test qualitatively detects infectious mononucleosis antibodies in human whole blood, serum or plasma specimens.
STIK 5 PANEL THC/OP1/COC/MET/PCP
Intend Use D5 Stik THC/OP1/COC/AMP or MET panel Assay is a simple, one-step immunochromatographic test for the rapid, qualitative detection of THC, opiates, cocaine, amphetamine or methamphetamineand/or their metabolites in human urine.
EUA AUTHORIZED COVID-19 FLU A&B
Intend Use Covid-19/Flu A&B test is a lateral flow immunoassay for intended for the in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS-Cov-2, influenza A and/or influenza B directly from anterior nasal or nasopharyngeal swab specimens obained from individuals, who are suspected of respiratory viral infection consistent with COVID-19.